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Zona pellucida (ZP) is an extracellular matrix that surrounds the mammalian oocyte. 
The rat ZP is composed of three major glycoproteins: ZP1, ZP2 and ZP3. As a 
primary sperm receptor, ZP3 has been utilised as an immunogen to prevent 
fertilisation of the ovum. Unfortunately, the availability of ZP3 protein is always 
limited and purified protein is not available. DNA vaccination is therefore an 
excellent alternative.  
 
ZP3 cDNA was amplified from R. rattus diardii ovary as a first step towards the 
development of ZP3-based DNA vaccine. The ZP3 gene has an open reading frame 
of 1272 nucleotides encoding a polypeptide of 424 amino acid residues which shares 
87% identity with mouse homologue. The anti-fertility polynucleotide vaccine was 
generated by placing ZP3 gene into a mammalian plasmid expression vector. 
Plasmid containing the entire ZP3 gene sequence was designated pcDNA/1300. 
Meanwhile, constructs pcDNA/720 and pcDNA/580 comprised partial ZP3 gene 
encoding the N-terminal and C-terminal half of the protein respectively. In vitro 
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transfection of mammalian cells with these plasmids DNA led to their cytosolic 
expression. Sperms were attracted and bound to cells harbouring pcDNA/1300 and 
pcDNA/580 because these two constructs encoded the sperm-combining sites of 
ZP3.  
 
Administration of these DNA vaccines resulted in vivo expression of ZP3 protein, 
which in turn stimulates specific cellular and humoral immune responses directed 
against self-ZP3 protein bearing cells or oocytes. Lacking or destruction of such cells 
resulted in an effective contraception in female animals. The ovarian dysfunction 
was characterised by excessive depletion of follicles and an increase in the number 
of oocyte-free cell clusters. The integrity of most follicles was challenged, as it was 
significantly infiltrated by immune cells. These ZP3 specific immune cells were 
shown to be a mixture of CD4+ and CD8+ T-lymphocytes subsets. Alterations in 
ovarian function were also evidenced when vaccinated animals were no longer 
sensitive to an intensive exogenous hormonal (hCG) treatment. Among the three 
constructs, pcDNA/1300 is the most effective contraceptive vaccine followed by 
pcDNA/580. The reduction in average litter size achieved by pcDNA/1300 was 
>90%. It is an excellent irreversible contraceptive vaccine as none of the vaccinated 
rats showed signs of recovery after three injections. In contrast, rats vaccinated with 
pcDNA/580 regained fertility over an extended period. On the other hand, 
vaccination with pcDNA/720 construct has no significant impact on rat fertility. 
Hence, special attention was given to pcDNA/1300. 
 
In DNA vaccination, the role of cell-mediated immune response was pre-eminent as 
the titre of ZP3-antibody produced was significantly low. Relatively, vaccination 
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with recombinant ZP3 protein expressed by yeast cells, P. pastoris stimulated strong 
antibody response, but no correlation between antibody titres and infertility was 
observed. Similarly, when the cytokines IL-4 gene was co-immunised along with 
pcDNA/1300, a dramatic increase in ZP3 antibody level did not enhance the efficacy 
of pcDNA/1300. Indeed by driving the immune response of pcDNA/1300 towards 
Th2 direction, this weakened its effectiveness in preventing fertilisation.  
 
Construct pHumoral-ZP3 was assembled as an attempt to improve the potency of 
pcDNA/1300. Modification of pcDNA/1300 with viral NP conjugation produced a 
significant enhancement on the levels of ZP3 antibody. The magnitude of the 
antibody response was comparable to that generated through the use of cytokine 
genetic adjuvant, IL-4. However, despite high ZP3 antibody titres, rats vaccinated 
with pHumoral-ZP3 produced normal litter size.  
 
This study demonstrated the application of a ZP3-based DNA vaccine in fertility 
control. The results obtained are extremely encouraging for the development of a 
vaccine for lasting rat population control. Meanwhile, the current DNA construct 
serves as excellent model for the generation of similar vaccines to prevent individual 
animals from conceiving. As a result, the expensive and complicated invasive 
procedures like surgery and castration can be avoided. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
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Zona palusida (ZP) adalah matriks ektraselular yang mengelilingi oosit mamalia. ZP 
tikus terdiri daripada tiga glikoprotein utama: ZP1, ZP2 dan ZP3. Selaku reseptor 
sperma primer, ZP3 telah digunakan sebagai imunogen untuk mencegah 
persenyawaan ovum. Namun, protein ZP3 yang tersedia ada adalah terhad dan 
protein yang ditulinkan tidak tersedia ada. Oleh itu, penvaksinan DNA adalah 
alternatif terbaik. 
 
ZP3 cDNA telah diamplify dari ovari R. rattus diardii dalam langkah permulaan 
membangunkan vaksin DNA berasaskan ZP3. Gen ZP3 mempunyai kerangka 
bacaan terbuka (ORF) 1272 nucleotida yang mengkodkan polipeptida sepanjang 424 
asid amino yang mana berkongsi 87% persamaan dengan homolog mencit. Vaksin 
polinukleotida anti-subur dihasilkan dengan menempatkan gen ZP3 ke dalam vector 
pengekspresan plasmid mamalia. Plasmid yang mengandungi kesuluruhan jujukan 
gen ZP3 dinamakan pcDNA/1300. Sementara itu, binaan pcDNA/720 dan 
pcDNA/580 masing-masing mengandungi separuh dari bahagian gen ZP3 yang 
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mengkodkan terminal-N dan terminal-C. Transfeksi in-vitro sel mamalia dengan 
plasmid DNA ini menyebabkan ekspresi sitosol. Sperma-sperma tertarik dan terikat 
kepada sel yang mengandungi pcDNA/1300 dan pcDNA/580 kerana kedua-dua 
binaan ini mengkodkan tapak pelekatan sperma ZP3.  
 
Pengambilan vaksin-vaksin DNA ini mengakibatkan ekspresi protein ZP3 in-vivo, 
seterusnya merangsangkan tindakbalas imun sel-sel khusus dan humoral menentang 
sel-sel yang mengandungi protein ZP3 ataupun oosit-oosit. Kekurangan atau 
kemusnahan sel-sel seperti ini menyebabkan penghamilan pada haiwan betina 
dicegah dengan berkesan. Kegagalan fungsi ovari dicirikan dengan penghabisan 
melampau folikel-folikel dan meningkatnya bilangan kelompok-kelompok sel oosit 
bebas. Integriti kebanyakan folikel ternyata dicabar oleh sel-sel imun yang 
menyusup masuk. Sel-sel imun khas ZP3 ini dikenalpasti sebagai campuran subset 
T-limfosit CD4+ dan CD8+. Perubahan dalam fungsi ovari turut dibuktikan apabila 
haiwan yang divaksinkan tidak lagi peka kepada ransangan hebat hormon (hCG) 
luar. Antara ketiga-tiga binaan, pcDNA/1300 adalah vaksin pencegah penghamilan 
yang paling berkesan diikuti dengan pcDNA/580. Pengurangan saiz purata anak 
yang dicapai oleh pcDNA/1300 adalah >90%. Ia adalah vaksin pencegah 
penghamilan tidak keterbalik yang bagus kerana tiada tikus-tikus yang divaksin 
menujukkan tanda pulih selepas tiga kali suntikan. Sebaliknya, tikus-tikus yang 
divaksinkan dengan pcDNA/580 kembali subur apabila jangkamasa dilanjutkan. 
Dalam hal yang lain pula, penvaksinan dengan binaan pcDNA/720 tidak mempunyai 
sebarang kesan yang nyata terhadap kesuburan tikus. Maka, perhatian istimewa 
diberikan kepada pcDNA/1300. 
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Dalam penvaksinan DNA, tindakbalas imun dengan perantaraan sel memainkan 
peranan penting sebab titer antibodi ZP3 yang dihasilkan terlalu rendah. Secara 
relatifnya, penvaksinan dengan protein ZP3 rekombinan yang diekspreskan oleh sel-
sel yis, P. pastoris meransang tindakbalas antibodi yang kuat. Akan tetapi, tidak pula 
dilihat perkaitan antara titer antibodi dan ketidaksuburan. Keadaan yang sama 
berlakuapabila gen sitokin IL-4 diko-imunkan bersama dengan pcDNA/1300, 
kenaikan paras antibodi ZP3 tidak juga meningkatkan keefisyenan pcDNA/1300. 
Sebetulnya, tindakbalas imun pcDNA/1300 dituju ke hala Th2 telah melemahkan 
keperkesanannya dalam menghalang persenyawaan.  
 
Binaan pHumoral-ZP3 dianggap dapat memperbaiki potensi pcDNA/1300. 
Pengubahan pcDNA/1300 dengan konjugasi virus NP ternyata sekali telah 
menaikkan paras antibodi ZP3. Kadar tindakbalas antibodi adalah setanding dengan 
penggunaan genetik adjuvant sitokin, IL-4. Tetapi, walaupun titer antibodi adalah 
tinggi, tikus-tikus yang diberi vaksin melahirkan saiz anak yang normal.  
 
Kajian ini menujukkan penggunaan vaksin DNA berdasarkan ZP3 dalam kawalan 
kesuburan. Keputusan yang diperolehi sangat menggalakkan dalam membangunkan 
vaksin untuk kawalan populasi tikus selamanya. Dalam pada itu, binaan vaksin DNA 
ini merupakan model yang sangat baik untuk menghasilkan vaksin yang serupa bagi 
mencegah individu binatang daripada mengandung. Dengan demikian, cara-cara 
pelanggaran yang mahal dan sulit seperti pembedahan pengembirian dapat dielakan.     
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CHAPTER I 
INTRODUCTION 
 
For many years, rats have been a persistent problem to the country. Current control 
methods such as trapping, shooting and poisoning are not long-term solutions 
because of the intrinsic capacity of rats to rapidly replace those killed. Curbing the 
reproductive potential of the pest therefore is a more effective way to control it. 
Immunocontraception is a new concept of controlling fertility by using a vaccine. It 
aims to trick the host’s immune system into generating an immune reaction against 
cells or molecules that are essential for reproduction, such as hormones (egs. FSH 
and LH) that trigger the maturation and release of egg cells in the female or a 
continuous production of sperms in the male, or against the gametes themselves or 
against pregnancy-related hormones (eg. progesterone). If successful, this approach 
will effectively reduce the rat population density. It is also less costly, more humane 
and environmental friendly as compared to existing methods, mentioned earlier.  
 
There are three major steps toward the development of a contraceptive vaccine: 
selecting a potential agent to deliver the vaccine, identifying the antigen to use in the 
vaccine, and ensuring that the vaccine is species-specific. In an earlier study (Lai et 
al. 1998), rat cytomegalovirus (RCMV) was identified as a suitable vehicle to carry 
the vaccine. A narrow host range, the capability of establishing latent and persistent 
infections, and having a large DNA genome are some of the main features that make 
this virus a promising vector for fertility-associated genes. Following the above 
strategies, the next mission is to isolate and characterise the relevant antigen, 
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reassemble it into functional vaccine and conduct studies to evaluate its efficacy 
before incorporating it into the delivery system.  
 
Basically, target antigens for immunocontraception can be grouped into two 
categories: reproductive hormones and gamete proteins. In the present study, the 
latter are preferred because they are tissue-specific and non-circulatory; 
complications arising from an immune complex formation should not happen. 
Evidence to support this hypothesis is found in nature. Several clinical studies have 
shown the association of antibodies against sperm antigens with an otherwise 
unexplained infertility (Scarselli et al. 1973; Mettler et al. 1974; Ingerslev, 1981; 
Witkin and David, 1986). Autoantibodies against the egg protein, zona pellucida 
(ZP) have also been documented (Nishimoto et al. 1980; Buckshee and Mhaskar, 
1985; Kamada et al. 1992) in infertile patients that otherwise appear healthy, 
indicating that an immunological block to fertility is prevalent in the human 
situation, without any side effects. The focus is finally given to egg proteins because 
in most species, the ova surfaces consist of only three proteins and their individual 
functions are well understood compared to sperm antigens.     
 
Zona pellucida is an acellular translucent matrix that surrounds the mammalian 
oocytes. It serves as the docking site for initial recognition and binding of the sperm 
to the oocyte in a species-specific manner, induces the acrosome reaction in the 
zona-bound sperm, blocks polyspermy, and protects the pre-implanted blastocyst. 
The critical involvement of ZP in the fertilisation process, together with its tissue-
specific nature, has made it one of the promising target antigens for the development 
of an immunocontraceptive vaccine. Molecular composition analysis has revealed 
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that the ZP extracellular matrix is composed of three major glycoproteins with high 
homology among species (Harris et al. 1994; Zhu and Naz, 1999). These 
glycoproteins have been named as ZP1, ZP2 and ZP3 based on their mobility in 
SDS-PAGE. In rodents, ZP3 acts as a primary sperm receptor with a specific class of 
O-linked oligosaccharides involved in sperm binding (Wassarman, 1990).  
 
The use of ZP as a possible means of birth control has long been investigated. 
Porcine ZP has been extensively utilised in these studies due to its high availability 
at the abattoirs. Immunisation with porcine ZP has resulted in significant zonae 
antibody titres and inhibition of fertility in a number of species including rabbits 
(Skinner et al. 1984), hamsters (Hasegawa et al. 1992), dogs (Mahi-Brown et al. 
1988), primates (Paterson et al. 1992; Bagavant et al. 1994), horses (Kirkpatrick et 
al. 1990, 1996) and deer (Miller et al. 1999, 2000). Unfortunately, rats and mice 
immunised with the identical immunogen remained fertile (Wood et al. 1981; Sacco 
et al. 1981). Hence, ‘self’ ZP is required to suppress fertility in these animals. 
Similar to porcine ZP, the murine ZP (mZP) has been explored in some details. The 
mZP3 antigens either in the form of peptides or recombinant proteins have been 
demonstrated to induce antibody-mediated contraception (Sacco, 1979; East et al. 
1985; Miller et al. 1989; Zhang et al. 1997) as well as autoimmune oophoritis in 
mice (Rhim et al. 1992; Lou et al. 1996). In contrast, little information is available 
on rat ZP, particularly, its use in immunocontraception. However, based on the 
established knowledge of mZP, the present study has been designed to develop a 
special contraceptive vaccine to control the rat population. Genetic vaccination can 
lead to active protein production in vivo and induces a broad spectrum of immune 
responses (Ulmer et al. 1993; Kowalczyk and Ertl, 1999). As such, hypothetically, a 
